Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that ...

BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated ...

The Trump administration’s vaccine advisers are bringing up an old debate: whether it’s time to wipe out the last small ...

The Trump administration’s new vaccine advisers on Thursday endorsed this fall’s flu vaccinations for just about every ...

The Expanded Programme on Immunization (EPI) is a cornerstone of global infectious disease prevention. In 2024, WHO celebrated the 50th anniversary of this initiative.1 Since its inception in 1974, ...

Global efforts to protect children against diseases like measles, polio and tuberculosis have stalled since 2010, leaving ...

This article is authored by Dr Ashok Bhardwaj and Dr Bhupendra Tripathi, deputy director, Infectious Diseases and Vaccine ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...